Vandewouw, Marlee M. http://orcid.org/0000-0002-4505-0306
Choi, EunJung
Hammill, Christopher
Arnold, Paul http://orcid.org/0000-0003-2496-4624
Schachar, Russell
Lerch, Jason P.
Anagnostou, Evdokia
Taylor, Margot J.
Funding for this research was provided by:
Ontario Brain Institute (IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02)
Article History
Received: 19 December 2019
Revised: 14 April 2020
Accepted: 21 April 2020
First Online: 2 November 2020
Conflict of interest
: E.A. has served as a consultant to Roche and quadrant therapeutics. She has received in kind support from AMO pharma, royalties from APPI and Springer, and editorial honoraria from Wiley. She also holds a patent for the device, “Anxiety Meter.” R.J.S. has consulted with Highland Therapeutics, Eli Lilly and Co., and Purdue Pharma. He has commercial interest in a cognitive rehabilitation software company, “eHave”. The remaining authors (M.M.V., E.J.C., C.H., P.A., J.P.L. and M.J.T.) declare no biomedical financial interests or potential conflicts of interest.